Open Access Government has a large variety of Scientific Research and Innovation information that is available in this category.
This section explores the latest breakthroughs in all aspects of science: including Biology, Chemistry, Physics, Psychology and Sociology. There is extensive research on psychological and social patterns that occur in everyday life.
Information is available on scientific policies that the government might adopt. Along with the changes and developments of global space policy. We cover the ongoing rise of anti-microbial resistance (AMR) and cancer research breakthroughs along with countries and their own individual research priorities.
Within this category we explore the massive increase and growth in CBD research and production, there is a lot of interesting information available.
Open Access Government explores the work of the American Association for the Advancement of Science (AAAS), and how the organisation continues to ensure that all of society benefit from scientific innovation.
New data from the REACT study finds that the prevalence of COVID is down by 60% in one month, but primary school children have the highest COVID infection levels.
Scientists have developed an implantable sensor using gold nanoparticles, which can function in the human body for "several months" to report health changes.
Here, Open Access Government learns all about the initiatives of the Japan Society for the Promotion of Science to promote scientific excellence on both a national and global scale.
Open Access Government discusses the importance of funding visionaries, explorers and innovators who are searching for scientific and technical breakthroughs in Canada.
Researchers have discovered a deadly new snake species in Asia, which has been named Suzhen's krait after the mythical figure of Bai Su Zhen - a snake goddess who saved a lot of human lives.
Here, M. Danner & R. M. Winglee* describe the viability of microbial sampling within impact lander craters in extraplanetary ice, including the possibility of life beyond our planet.
Sherry A. Southerland and Jennifer Schellinger tell us what we need to know about Learning Through Collaborative Design-Professional Development (LCD PD) in this special science education focus.
We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.
A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.
Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
In an investigation of over seven million pupils, researchers found that Black pupils have the highest rate of autism in the UK - they further noticed that there is "little research" on the existence of autism in ethnic minorities.
Richie Kohman, Synthetic Biology Platform Lead at Wyss Institute at Harvard, explains the use of next-generation sequencing to analyse biological tissues in a spatially resolved context.
Mutlu Ă–zcan, Prof. Dr Dr h.c., PhD from the University of ZĂĽrich, highlights Reconstructive Dentistry through new biomaterials and technologies, including the associated changes and challenges.